ArticleFrontiers in oncology2019

MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.

Mingshan Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.